Expression of phosphorylated p27Kip1 protein and jun activation domain-binding protein 1 in human pituitary tumors

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 6, 2002, Pages 2635-2643

  Korbonits, Márta ^a   Chahal, Harvinder S ^b   Kaltsas, Gregory ^c   Jordan, Suzanne ^d   Urmanova, Yulduz ^a   Khalimova, Zamira ^a   Harris, Philip E ^b   Farrell, William E ^c   Claret, Francois Xavier ^d   Grossman, Ashley B ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c KEELE UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; JUN ACTIVATION DOMAIN BINDING PROTEIN; KI 67 ANTIGEN; PROTEIN P27; UNCLASSIFIED DRUG;

ARTICLE; CELL LABELING; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHYSIS TUMOR; KNOCKOUT MOUSE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALIA;

EID: 18444413232     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.6.8517     Document Type: Article

References (52)

1. Cancer cell cycles
2. Multiple functions of p27(Kip1) and its alterations in tumor cells: A review
3. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors
4. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1)
5. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice
6. The murine gene p27Kip1 is haplo-insufficient for tumour suppression
7. p27Kip1: Chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors
8. Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours
9. Mutation and expression analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in pituitary tumors
10. Molecular analysis of p21 and p27 genes in human pituitary adenomas
11. DNA methylation regulates p27kip1 expression in rodent pituitary cell lines
12. Kip1 gene and trisomy 12 in a subset of pituitary adenomas
13. kip1
14. Bcl-2 retards cell cycle entry through p27(Kip1), pRB relative p130, and altered E2F regulation
15. Kip1
16. Cyclin E-CDK2 is a regulator of p27Kip1
17. A new group of conserved coactivators that increase the specificity of AP-1 transcription factors
18. Kip1 is instigated by Jab1
19. Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors
20. Aberrant p27kip1 expression in endocrine and other tumors
21. Brief, high-temperature heat denaturation (pressure cooking): A simple and effective method of antigen retrieval for routinely processed tissues
22. High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: Inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers
23. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas
24. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients
25. p27 expression and gastric carcinoma
26. Decreased levels of the cell cycle inhibitor p27/kip1 protein: Prognostic implications in primary breast cancer
27. The release of leptin and its effect on hormone release from human pituitary adenomas
28. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors
29. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation
30. Cell-free degradation of p27(kip1), a G1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome
31. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27
32. A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase
33. Moving protein heads for breakdown
34. Nuclear accumulation of cyclin E/Cdk2 triggers a concentration-dependent switch for the destruction of p27Xic1
35. A novel protein complex involved in the signal transduction processing similar to 26S proteasome subunits
36. Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity
37. Cyclin E-mediated elimination of p27 requires its interaction with the nuclear pore-associated protein mNPAP60
38. Characterization of the mouse JAB1 cDNA and protein
39. Differentiation-associated expression and intracellular localization of cyclin-dependent kinase inhibitor p27(KIP1) and c-Jun co-activator JAB1 in neuroblastoma
40. CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis
41. Kip1 in human pituitary adenomas
42. Transforming growth factor-β and p27 expression in pituitary cells
43. Transforming growth factor-β, transforming growth factor-β receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries
44. Assessment of mitotic activity in pituitary adenomas and carcinomas
45. Ki-67 labelling index and invasiveness among anterior pituitary adenomas: Analysis of 103 cases using the MIB-1 monoclonal antibody
46. Are markers of proliferation valuable in the histological assessment of pituitary tumours?
47. Cyclin D and cyclin E expression in normal and adenomatous pituitary
48. Glucocorticoid receptor expression in nontumorous human pituitaries and pituitary adenomas
49. Expression of glucocorticoid receptor gene isoforms in corticotropin-secreting tumors
50. Expression of 11β-hydroxysteroid dehydrogenase type 1 and 2 in the pituitary gland: Induction of type 2 isozyme expression in corticotrophinomas
51. Corticotroph, somatotroph and mammotroph cell kinetics in the postnatal infant female rat
52. Proliferation parameters for pituitary adenomas